CELG

Celgene Corporation News Headlines

$121.53
*  
1.82
1.48%
Get CELG Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Celgene Vs. Johnson & Johnson: The Race In Blood Cancer
7/1/2013 4:17:00 PM - Seeking Alpha


Sorrento Has Multiple Shots On Goal, Worth A Closer Look
6/20/2013 3:35:00 PM - Seeking Alpha


IPO Preview: Bluebird Bio
6/19/2013 5:33:00 AM - Seeking Alpha


An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
6/18/2013 11:34:00 AM - Seeking Alpha


Cramer's Mad Money - The Kids' Portfolio (6/13/13)
6/14/2013 4:28:00 AM - Seeking Alpha


Novartis: Drug Pipeline And New Drug Applications
6/13/2013 4:35:00 PM - Seeking Alpha


Warning: This Might Be The Most Overvalued Sector In The Market
6/12/2013 8:47:00 PM - Seeking Alpha


Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
6/12/2013 10:27:00 AM - Seeking Alpha


When It Comes To Biotech, Diversity Is Key
6/12/2013 7:51:00 AM - Seeking Alpha


Celgene Moves Fast And Early In Expanding Its Pipeline
6/10/2013 1:45:00 PM - Seeking Alpha


Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy
6/5/2013 5:53:00 AM - Seeking Alpha


Celgene Stock Still Has Plenty Of Room To Grow Due To A Strong Product Line
6/4/2013 2:46:00 PM - Seeking Alpha


As Pfizer Eyes It, Celgene Calls Cellceutix
5/31/2013 8:36:00 AM - Seeking Alpha


Investing In Cancer Research Is Worth The Risk: Echo He
5/24/2013 11:59:00 AM - Seeking Alpha


Cramer's Mad Money - The Miraculous Six Flags (5/22/13)
5/23/2013 6:56:00 AM - Seeking Alpha


Celgene: Apremilast For Psoriatic Arthritis Offers Upside
5/14/2013 12:50:00 PM - Seeking Alpha


Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
5/12/2013 6:21:00 PM - Seeking Alpha


Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
5/12/2013 6:06:00 PM - Seeking Alpha


Cramer's Mad Money - 10 Things To Watch In The Week Ahead (5/3/13)
5/5/2013 6:59:00 AM - Seeking Alpha


Biotechnology: Strong Fundamentals Are The Basis Of Strong Performance
5/3/2013 5:59:00 AM - Seeking Alpha


Biotech Bulls Can Ignore The Warning Signs At Their Peril
5/2/2013 8:14:00 PM - Seeking Alpha


Cramer's Mad Money - 16 Things To Watch In The Week Ahead (4/26/13)
4/28/2013 5:07:00 AM - Seeking Alpha


Cramer's Mad Money - Sinclair's Remarkable Transformation (4/26/13)
4/28/2013 4:22:00 AM - Seeking Alpha


Cramer's Mad Money - Why Analysts Were Wrong About Microsoft (4/25/13)
4/26/2013 7:20:00 AM - Seeking Alpha


Celgene: Going Higher And Higher
4/25/2013 10:23:00 AM - Seeking Alpha